These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38441205)

  • 1. A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey.
    Ünsal H; Caka C; Bildik HN; Esenboğa S; Kupesiz A; Kuşkonmaz B; Cetinkaya DU; van der Burg M; Tezcan İ; Çağdaş D
    Scand J Immunol; 2024 Jan; 99(1):e13335. PubMed ID: 38441205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
    Mousavi Khorshidi MS; Seeleuthner Y; Chavoshzadeh Z; Behfar M; Hamidieh AA; Alimadadi H; Sherkat R; Momen T; Behniafard N; Eskandarzadeh S; Mansouri M; Behnam M; Mahdavi M; Heydarazad Zadeh M; Shokri M; Alizadeh F; Movahedi M; Momenilandi M; Keramatipour M; Casanova JL; Cobat A; Abel L; Shahrooei M; Parvaneh N
    J Clin Immunol; 2023 Nov; 43(8):1941-1952. PubMed ID: 37584719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC Class II Deficiency: Clinical, Immunological, and Genetic Insights in a Large Multicenter Cohort.
    Gulec Koksal Z; Bilgic Eltan S; Topyildiz E; Sezer A; Keles S; Celebi Celik F; Ozhan Kont A; Gemici Karaaslan B; Sefer AP; Karali Z; Arik E; Ozek Yucel E; Akcal O; Karakurt LT; Yorgun Altunbas M; Yalcin K; Uygun V; Ozek G; Babayeva R; Aydogmus C; Ozcan D; Cavkaytar O; Keskin O; Kilic SS; Kiykim A; Arikoglu T; Genel F; Gulez N; Guner SN; Karaca NE; Reisli I; Kutukculer N; Altintas DU; Ozen A; Karakoc Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2024 Sep; 12(9):2490-2502.e6. PubMed ID: 38996837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.
    Naamane H; El Maataoui O; Ailal F; Barakat A; Bennani S; Najib J; Hassar M; Saile R; Bousfiha AA
    Eur J Pediatr; 2010 Sep; 169(9):1069-74. PubMed ID: 20414676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of the Bare lymphocyte syndrome.
    Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
    Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India.
    Aluri J; Desai M; Gupta M; Dalvi A; Terance A; Rosenzweig SD; Stoddard JL; Niemela JE; Tamankar V; Mhatre S; Bargir U; Kulkarni M; Shah N; Aggarwal A; Lashkari HP; Krishna V; Govindaraj G; Kalra M; Madkaikar M
    Front Immunol; 2019; 10():23. PubMed ID: 30778343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.
    Renella R; Picard C; Neven B; Ouachée-Chardin M; Casanova JL; Le Deist F; Cavazzana-Calvo M; Blanche S; Fischer A
    Br J Haematol; 2006 Sep; 134(5):510-6. PubMed ID: 16848795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.
    El Hawary RE; Mauracher AA; Meshaal SS; Eldash A; Abd Elaziz DS; Alkady R; Lotfy S; Opitz L; Galal NM; Boutros JA; Pachlopnik Schmid J; Elmarsafy AM
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):856-863. PubMed ID: 30170160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and HSCT Outcome for SCID in Turkey.
    Ikinciogullari A; Cagdas D; Dogu F; Tugrul T; Karasu G; Haskologlu S; Aksoylar S; Uygun V; Kupesiz A; Yildiran A; Gursel O; Ates C; Elhan A; Kansoy S; Yesilipek A; Tezcan I;
    J Clin Immunol; 2019 Apr; 39(3):316-323. PubMed ID: 30924026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
    Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
    J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre.
    Karaatmaca B; Cagdas D; Esenboga S; Erman B; Tan C; Turul Ozgur T; Boztug K; van der Burg M; Sanal O; Tezcan I
    Clin Exp Immunol; 2024 Feb; 215(2):160-176. PubMed ID: 37724703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
    Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
    Front Immunol; 2018; 9():2554. PubMed ID: 30450104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC II deficient infant identified by newborn screening program for SCID.
    Marcus N; Stauber T; Lev A; Simon AJ; Stein J; Broides A; Somekh I; Almashanu S; Somech R
    Immunol Res; 2018 Aug; 66(4):537-542. PubMed ID: 30084052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Immunological, and Molecular Features of Severe Combined Immune Deficiency: A Multi-Institutional Experience From India.
    Vignesh P; Rawat A; Kumrah R; Singh A; Gummadi A; Sharma M; Kaur A; Nameirakpam J; Jindal A; Suri D; Gupta A; Khadwal A; Saikia B; Minz RW; Sharma K; Desai M; Taur P; Gowri V; Pandrowala A; Dalvi A; Jodhawat N; Kambli P; Madkaikar MR; Bhattad S; Ramprakash S; Cp R; Jayaram A; Sivasankaran M; Munirathnam D; Balaji S; Rajendran A; Aggarwal A; Singh K; Na F; George B; Mehta A; Lashkari HP; Uppuluri R; Raj R; Bartakke S; Gupta K; Sreedharanunni S; Ogura Y; Kato T; Imai K; Chan KW; Leung D; Ohara O; Nonoyama S; Hershfield M; Lau YL; Singh S
    Front Immunol; 2020; 11():619146. PubMed ID: 33628209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II.
    Damoiseaux M; Damoiseaux J; Pico-Knijnenburg I; van der Burg M; Bredius R; van Well G
    Clin Immunol; 2022 Feb; 235():108932. PubMed ID: 35065305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
    Nekrep N; Jabrane-Ferrat N; Peterlin BM
    Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.
    Klein C; Cavazzana-Calvo M; Le Deist F; Jabado N; Benkerrou M; Blanche S; Lisowska-Grospierre B; Griscelli C; Fischer A
    Blood; 1995 Jan; 85(2):580-7. PubMed ID: 7812013
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.